Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHN
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
SCT200 Plus Platinum-based Chemotherapy in Head and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Individualized Radiation Dose Prescription in HNSCC Based on F-MISO-PET Hypoxia-Imaging
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma 2
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Validation of USPIO-enhanced MRI for Detection of Lymph Node Metastases in Head and Neck Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1
IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Vaccination With Flt3L, Radiation, and Poly-ICLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
SCT200 Injection in Patients With Head and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Enteral Omega 3 During Radiotherapy to Improve the Quality of Life and Functionality of Head and Neck Cancer Patients
- Status
- TERMINATED
- Phase
- NA
Phase 1 Study of BAY1905254 - An Early Clinical Research Study to Evaluate a New Drug Called Bapotulimab (BAY1905254) in the Expansion Cohort in Combination With Pembrolizumab in Head and Neck Cancer That Has Returned or is Discovered to be Metastatic and is Expressing PDL1.
- Status
- COMPLETED
- Phase
- PHASE1
A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Comparison of NETSPOT Imaging Versus F-FDG-PET in Head and Neck Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
HPV-E6-Specific Anti-PD1 TCR-T Cells in the Treatment of HPV-Positive NHSCC or Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE1